Kong Yue,Xu Yujin,Chen Mengyuan,et al.Dosimetric comparison on heart and lung among three modalities in treatment of thoracic esophageal cancer[J].Chinese Journal of Radiological Medicine and Protection,2017,37(11):832-837
Dosimetric comparison on heart and lung among three modalities in treatment of thoracic esophageal cancer
Received:February 21, 2017  Revised:February 21, 2017
DOI:10.3760/cma.j.issn.0254-5098.2017.11.006
KeyWords:Thoracic esophageal cancer  Dosimetric comparison  Volumetric intensity modulated arc therapy  Tomotherapy
FundProject:
Author NameAffiliationE-mail
Kong Yue Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China  
Xu Yujin Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China  
Chen Mengyuan Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China  
Li Pu Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China  
Yang Shuangyan Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China  
Chen Ming Department of Radiation Oncology, Zhejiang Cancer Hospital, Hangzhou 310022, China chenming@zjcc.org.cn 
Hits: 4928
Download times: 2692
Abstract::
      Objective To compare the dosimetric differences in heart and lung among three radiotherapy techniques in the treatment of thoracic esophageal cancer. Methods A total of 15 thoracic esophageal cancer patients treated in Zhejiang Cancer Hospital during the period of January 2015 to February 2016 were enrolled in this retrospective dosimetric study. Three radiotherapy treatment plans, including intensity-modulated radiotherapy (IMRT), volumetric intensity modulated arc therapy (VMAT) with Raystation 4.0v TPS, and tomotherapy (TOMO) plans with TomoTTM v2.0.5 TPS were generated for each patient with a prescribed dose of 60 Gy at 2 Gy per fraction. Dosimetric differences in planning target volume (PTV), heart, cardiac subunits and lung were compared. Results The mean volumes of PTV, heart and lung were (399±355), (671±274) and (3 907±1 717)cm3, respectively. Compared with VMAT and IMRT, TOMO reduced the maximum dose of PTV, heart, left atrium and lung (H=10.889, 7.433, 12.080, 11.401, P<0.05). No difference was observed in conformity or homogeneity among these three plans. Conclusions TOMO reduced the maximum dose to PTV, heart, left atrium and lung compared with VMAT and IMRT, However, no difference in conformity and homogeneity was observed. The impact of dosimetric advantage of TOMO needs further verification due to the interaction between heart and lung for thoracic esophageal cancer patients.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:12030772  On-line:0

v
Scan QR Code
&et=8400690B225D0A440FF4B0AFFBF4835C95F2AD227CBB8AC14A781D414A445FBFBAABECCF9CC2946EE94DEA416B92CA6FE1A2DB42945830C011017891734DA50060D57D9012C2F543EFD73DBEC880EDE16DD85F7A46B764C4D41E959D209D96D7A350D38153DAE3DAD51ABF74E8E73073&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=FA004A8A4ED1540B&aid=58EC03D86D1FF9203B328445BC9E6911&vid=&iid=708DD6B15D2464E8&sid=AB1DE136C335A86C&eid=2C8B50BA95995EA2&fileno=20171106&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="FA004A8A4ED1540B"; var my_aid="58EC03D86D1FF9203B328445BC9E6911";